Press "Enter" to skip to content

ANGLE raises £18mln as it gears up for Parsortix commercialisation – Proactive Investors UK

admin 0

ANGLE raises £18mln as it gears up for Parsortix commercialisation  Proactive Investors UK

ANGLE PLC (LON:AGL) – If all goes to plan, ANGLE’s Parsortix cancer-detecting blood test could get the green light from US regulators in early 2020, and …

“ovarian cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *